NDC 70461-120
FLUAD QUADRIVALENT
Influenza Vaccine, Adjuvanted
FLUAD QUADRIVALENT is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Seqirus, Inc.. The primary component is Influenza A Virus A/victoria/2454/2019 Ivr-207 (h1n1) Antigen (formaldehyde Inactivated); Influenza A Virus A/hong Kong/2671/2019 Ivr-208 (h3n2) Antigen (formaldehyde Inactivated); Influenza B Virus B/victoria/705/2018 Bvr-11 Antigen (formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Bvr-1b Antigen (formaldehyde Inactivated).
| Product ID | 70461-120_8d8ccb22-a14f-4877-a9c9-b039a689ddc4 |
| NDC | 70461-120 |
| Product Type | Vaccine |
| Proprietary Name | FLUAD QUADRIVALENT |
| Generic Name | Influenza Vaccine, Adjuvanted |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2020-02-21 |
| Marketing End Date | 2021-07-31 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125510 |
| Labeler Name | Seqirus, Inc. |
| Substance Name | INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Active Ingredient Strength | 15 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
| NDC Exclude Flag | N |
Packaging
NDC 70461-120-03
10 SYRINGE, GLASS in 1 CARTON (70461-120-03) > .5 mL in 1 SYRINGE, GLASS (70461-120-04)
| Marketing Start Date | 2020-02-21 |
| Marketing End Date | 2021-07-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 70461-120-02 [70461012002]
Fluvirin INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA103837 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2017-07-01 |
| Marketing End Date | 2018-06-30 |
NDC 70461-120-10 [70461012010]
Fluvirin INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA103837 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2017-07-01 |
| Marketing End Date | 2018-06-30 |
NDC 70461-120-12 [70461012012]
Fluvirin INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA103837 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2017-07-01 |
| Marketing End Date | 2018-06-30 |
NDC 70461-120-11 [70461012011]
Fluvirin INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA103837 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2017-07-01 |
| Marketing End Date | 2018-06-30 |
Drug Details
NDC Crossover Matching brand name "FLUAD QUADRIVALENT" or generic name "Influenza Vaccine, Adjuvanted"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 70461-120 | FLUAD QUADRIVALENT | influenza vaccine, adjuvanted |
| 70461-121 | FLUAD QUADRIVALENT | influenza vaccine, adjuvanted |
| 70461-122 | FLUAD QUADRIVALENT | INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (FORMALDEHYDE INACTIVATED) |
| 70461-018 | FLUAD | Influenza Vaccine, Adjuvanted |
| 70461-019 | FLUAD | Influenza Vaccine, Adjuvanted |
| 70461-020 | FLUAD | influenza vaccine, adjuvanted |
Trademark Results [FLUAD QUADRIVALENT]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 FLUAD QUADRIVALENT 88751629 not registered Live/Pending |
Seqirus UK Limited 2020-01-08 |
 FLUAD QUADRIVALENT 88237114 not registered Live/Pending |
Seqirus UK Limited 2018-12-20 |
 FLUAD QUADRIVALENT 79170997 4938922 Live/Registered |
Seqirus UK Limited 2015-07-06 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.